Biologics Regulatory Spine BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease byJosh SandbergNovember 17, 2025
Biologics Regulatory BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health byTim AllenNovember 5, 2024
Biologics BioRestorative Therapies Receives License from New York State Department of Health to act as Tissue Bank for Mesenchymal Stem Cell Processing byJosh SandbergMay 31, 2023
Biologics Spine BioRestorative Therapies Enters Agreement with Regenexx, Granting BRTX Exclusive License Rights for Intellectual Property Related to the Development and Commercialization of its BRTX-100® Disc Program to Treat Chronic Lumbar Disc Disease byChris StewartDecember 5, 2022
Regulatory Spine Top Stories Taiwan Food and Drug Administration Grants CTL Amedica Corp License to Market MATISSE™ ACIF Cage System byJosh SandbergSeptember 15, 2022
Financial Robotics Titan Medical Receives License Fee of $10 Million Upon Achievement of Milestone Under Medtronic Development Agreement byJosh SandbergMay 28, 2021
Regulatory Spine CTL Amedica Sets Sights on Asian Market: Receives TFDA License for Three Products byJosh SandbergSeptember 10, 2020
Financial Robotics Titan Medical Announces Development and License Agreements With Medtronic and Senior Secured Loan byChris StewartJune 4, 2020
Financial Recon Top Stories Conformis and Stryker Execute Development, License and Distribution Agreements byChris StewartOctober 1, 2019
